﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/jubilant-ingrevia-commissions-new-cgmp-facility-for-supplying-niacinamide-to-global-clients-16726</loc><lastmod>2025-01-31T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/natco-announces-approval-of-its-anda-for-everolimus-tablets-for-oral-suspension-16727</loc><lastmod>2025-01-31T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/granules-strengthens-adhd-portfolio-with-fda-approval-for-lisdexamfetamine-dimesylate-capsules-16728</loc><lastmod>2025-01-31T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/strides-reports-146-growth-in-q3-fy25-revenue-16729</loc><lastmod>2025-01-31T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biocon-posts-q3-fy25-pat-at-rs-25-cr-16730</loc><lastmod>2025-01-31T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>